Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Solco Healthcare US, LLC with status Current. The shortage was first posted on 07/14/2023. Reported reason: Shortage of an active ingredient
Shortage Details
- Status
- Current
- Company
- Solco Healthcare US, LLC
- Package NDC
- 43547-605-10
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10)
- Initial Posting
- 07/14/2023
- Revised Date
Reason
Shortage of an active ingredient